We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
-19.26%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.5B
AUM Growth
-$54.4M
Cap. Flow
+$398M
Cap. Flow %
26.54%
Top 10 Hldgs %
91.37%
Holding
30
New
1
Increased
18
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$227M
2
BN icon
Brookfield
BN
+$79.3M
3
AAPL icon
Apple
AAPL
+$41.1M
4
CABO icon
Cable One
CABO
+$17M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$7.78M

Top Sells

Rank Stock Value
1
MIST icon
Milestone Pharmaceuticals
MIST
+$6.13M
2
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$2.36M
3
INSP icon
Inspire Medical Systems
INSP
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 28.81%
2 Communication Services 8.18%
3 Technology 6.92%
4 Financials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
26
DELISTED
Verona Pharma
VRNA
$3.05M 0.2%
740,740
– –
CRNX icon
27
Crinetics Pharmaceuticals
CRNX
$8.92B
$2.42M 0.16%
164,453
+29,444
+22% +$603K
BHVN
28
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.84M 0.12%
54,100
+18,200
+51% +$832K
STIM icon
29
Neuronetics
STIM
$166M
$1.71M 0.11%
902,872
+166,294
+23% +$520K
1
2

Similar funds

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.52% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return
SPC
Stony Point Capital New York $1.24B AUM 32.69% 1-Year Est. Return
SC
Strategy Capital Los Altos, California $1.22B AUM 27.02% 1-Year Est. Return

Novo Holdings A/S's Q1 2020 Portfolio in Review

As of Q1 2020, Novo Holdings A/S held 30 positions worth $1.5B, down 3.5% from $1.55B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Novo Holdings A/S deployed $398M of net new capital in Q1 2020, opening 1 new position and adding to 18 existing holdings. Its largest new stake was Constellation Pharmaceuticals, Inc.: 168,381 shares worth $5.29M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 38% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Milestone Pharmaceuticals, an estimated $6.13M trimmed.

  • Novo Holdings A/S's largest Q1 2020 buy was Constellation Pharmaceuticals, Inc.: 168,381 shares worth $5.29M.
  • Novo Holdings A/S added most to Vanguard Morningstar Total Stock Market ETF in Q1 2020, an estimated $227M increase.
  • Novo Holdings A/S's biggest Q1 2020 reduction was Milestone Pharmaceuticals, cutting an estimated $6.13M.
  • Novo Holdings A/S's ten largest holdings make up 91% of its $1.5B portfolio in Q1 2020.
  • Novo Holdings A/S opened 1 new position and closed 0 in Q1 2020.
  • Novo Holdings A/S's portfolio value fell 3.5% quarter-over-quarter to $1.5B.

Based on Novo Holdings A/S's 13F filing for Q1 2020, filed 15 May 2020.